Lymphoma

• 

  Subject Areas on Research

  • (18)F-Flourodeoxy-Glucose PET/Computed Tomography in Brain Tumors: Value to Patient Management and Survival Outcomes. 
  • A Case with Purine Nucleoside Phosphorylase Deficiency Suffering from Late-Onset Systemic Lupus Erythematosus and Lymphoma. 
  • A Comparison of Late Mortality Among Survivors of Childhood Cancer in the United States and United Kingdom. 
  • A Lennert lymphoma with a helper-T-cell phenotype. 
  • A histopathologic study of 716 unselected eyes in patients with cancer at the time of death. 
  • A human immunoglobulin gene reduces the incidence of lymphomas in c-Myc-bearing transgenic mice. 
  • A monoclonal IgM with antibodylike specificity for phospholipids in a patient with lymphoma. 
  • A mosaic analysis system with Cre or Tomato expression in the mouse. 
  • A multicenter pilot evaluation of the National Institutes of Health chronic graft-versus-host disease (cGVHD) therapeutic response measures: feasibility, interrater reliability, and minimum detectable change. 
  • A neural network to predict symptomatic lung injury. 
  • A new preparatory regimen for autologous bone marrow transplantation for patients with lymphoma. 
  • A novel catecholamine-activated adenosine cyclic 3',5'-phosphate independent pathway for beta-adrenergic receptor phosphorylation in wild-type and mutant S49 lymphoma cells: mechanism of homologous desensitization of adenylate cyclase. 
  • A prospective, open-label study of single-dose ciprofloxacin absorption after chemotherapy in patients with malignancy. 
  • A randomized comparison between rasburicase and allopurinol in children with lymphoma or leukemia at high risk for tumor lysis. 
  • A surgical oncology perspective on AIDS. 
  • A variant of the LRP4 gene affects the risk of chronic lymphocytic leukaemia transformation to Richter syndrome. 
  • ATM regulates a DNA damage response posttranscriptional RNA operon in lymphocytes. 
  • Acute DNA damage activates the tumour suppressor p53 to promote radiation-induced lymphoma. 
  • Acute graft-versus-host disease: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexate. 
  • Advances in radiotherapy for tumors involving the mediastinum. 
  • Age cutoff in lymphoma diagnosis. 
  • Aggressive Phenotype of Intravascular Lymphoma Relative to Other Malignant Intraabdominal Tumors Requiring Vascular Reconstruction. 
  • Alpha-fetoprotein-specific genetic immunotherapy for hepatocellular carcinoma. 
  • Anti proliferative activity of ELACY (CP-4055) in combination with cloretazine (VNP40101M), idarubicin, gemcitabine, irinotecan and topotecan in human leukemia and lymphoma cells. 
  • Antibody isotype-specific engagement of Fcgamma receptors regulates B lymphocyte depletion during CD20 immunotherapy. 
  • Antibody-dependent cytolysis (ADCC) of tumor cells by activated murine macrophages is a two-step process: quantification of target binding and subsequent target lysis. 
  • Application of a panel of antiganglioside monoclonal antibodies to cytologic specimens. 
  • Association of myosin light chain kinase with lymphocyte membrane-cytoskeleton complex. 
  • Association of socioeconomic status with autologous hematopoietic cell transplantation outcomes for lymphoma. 
  • Association of the human type C retrovirus with a subset of adult T-cell cancers. 
  • Atm deficiency affects both apoptosis and proliferation to augment Myc-induced lymphomagenesis. 
  • Autologous marrow transplantation for malignant lymphoma: a report of 101 cases from Seattle. 
  • B lymphocytes: how they develop and function. 
  • Beta-adrenergic receptor kinase: identification of a novel protein kinase that phosphorylates the agonist-occupied form of the receptor. 
  • Beyond Mirels: Factors Influencing Surgical Outcome of Metastasis to the Extremities in the Modern Era. 
  • Bilateral Optic Nerve Infiltration in High-Grade Systemic Lymphoma With Secondary Combined Central Retinal Artery and Vein Occlusions. 
  • Block-diagonal discriminant analysis and its bias-corrected rules. 
  • Bone marrow transplantation. Part II--autologous. 
  • Busulfan, cyclophosphamide and fractionated total body irradiation as a preparatory regimen for marrow transplantation in patients with advanced hematological malignancies: a phase I study. 
  • CALGB 150905 (Alliance): rituximab broadens the antilymphoma response by activating unlicensed NK cells. 
  • Calcium/Calmodulin Dependent Protein Kinase Kinase 2 Regulates the Expansion of Tumor-Induced Myeloid-Derived Suppressor Cells. 
  • Cancer in pregnancy: a review of the literature. Part II. 
  • Candidate counterparts of Sézary cells and adult T-cell lymphoma-leukaemia cells in normal peripheral blood: an ultrastructural study with the immunogold method and monoclonal antibodies. 
  • Cardiovascular Risk Factors in Survivors of Childhood Hematopoietic Cell Transplantation Treated with Total Body Irradiation: A Longitudinal Analysis. 
  • Cardiovascular risk factors, radiation therapy, and myocardial infarction among lymphoma survivors. 
  • Cat-scratch disease simulating lymphoma. 
  • Cell lines producing human T-cell lymphoma virus show altered HLA expression. 
  • Cell-free heterologous desensitization of adenylyl cyclase in S49 lymphoma cell membranes mediated by cAMP-dependent protein kinase. 
  • Central nervous system cancers: Clinical Practice Guidelines in Oncology. 
  • Cerebral lymphoma in an adenosine deaminase-deficient patient with severe combined immunodeficiency receiving polyethylene glycol-conjugated adenosine deaminase. 
  • Chemotherapy in the management of intraocular lymphoma. 
  • Childhood Hodgkin Lymphoma: Think DADA2. 
  • Clinical applications of PET in oncology. 
  • Clinical features and outcome of primary pancreatic lymphoma. 
  • Clinical roundtable monograph: CD30 in lymphoma: its role in biology, diagnostic testing, and targeted therapy. 
  • Combination chemotherapy with vincristine, cyclophosphamide, and prednisone producing long-term remission of a transplanted canine lymphoma. 
  • Combined chemoseparation and immunoseparation of clonogenic T lymphoma cells from human bone marrow using 2'-deoxycoformycin, deoxyadenosine, 3A1 monoclonal antibody, and complement. 
  • Combined modality therapy of advanced non-Hodgkin's lymphoma: an analysis of remission duration and survival in 95 patients. 
  • Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures. 
  • Comparison of non-myeloablative conditioning regimens for lymphoproliferative disorders. 
  • Constitutive expression of placental lactogen in pancreatic beta cells: effects on cell morphology, growth, and gene expression. 
  • Costimulation molecule expression and subset distribution of blood dendritic cells in normal children and newly diagnosed pediatric leukemia and lymphoma patients. 
  • Crohn's disease patients' risk-benefit preferences: serious adverse event risks versus treatment efficacy. 
  • Cross-reacting antigens on L5178Y cells which serve as targets for cytotoxic T-lymphocyte lysis during establishment of the tumor dormant state. 
  • Current concepts. Cancer in children. 
  • Current perspectives on the treatment of double hit lymphoma. 
  • Cutaneous T cell lymphoma. Lymphocyte phenotype analysis after anti-thymocyte globulin therapy. 
  • Cutaneous T-cell lymphoma presenting as a rapidly enlarging ocular adnexal tumor. 
  • Cyclophosphamide, doxorubicin, vincristine, and prednisone for primary central nervous system lymphoma: short-duration response and multifocal intracerebral recurrence preceding radiotherapy. 
  • Cyclosporine inhibition of CH series murine B-cell lymphomas. 
  • Cyclosporine inhibition of a murine B cell lymphoma. 
  • DTRMWXHS-12, a novel Bruton tyrosine kinase inhibitor, in combination with everolimus and pomalidomide in patients with relapsed/refractory lymphomas: An open-label, multicenter, phase 1a/1b study. 
  • Dendritic cells improve the generation of Epstein-Barr virus-specific cytotoxic T lymphocytes for the treatment of posttransplantation lymphoma. 
  • Development of scalable lymphatic system in the 4D XCAT phantom: Application to quantitative evaluation of lymphoma PET segmentations. 
  • Diagnosis of ocular surface lesions using ultra-high-resolution optical coherence tomography. 
  • Diagnostic and predictive biomarkers for lymphoma diagnosis and treatment in the era of precision medicine. 
  • Diet, physical activity, and body composition changes during the first year of treatment for childhood acute leukemia and lymphoma. 
  • Disseminated infection with rapidly growing mycobacteria. 
  • Dynamic assessment of quality of life after autologous bone marrow transplantation. 
  • Dysfunction of the TP53 tumor suppressor gene in lymphoid malignancies. 
  • EBV-positive diffuse large B-cell lymphoma of the elderly: 2016 update on diagnosis, risk-stratification, and management. 
  • EL-4 metastases in spleen and bone marrow suppress the NK activity generated in these organs. 
  • EUS-guided 19-gauge trucut needle biopsy for diagnosis of lymphoma missed by EUS-guided FNA. 
  • Economic evaluation of filgrastim, sargramostim, and sequential sargramostim and filgrastim after myelosuppressive chemotherapy. 
  • Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma. 
  • Effect of HLA-matching recipients to donor noninherited maternal antigens on outcomes after mismatched umbilical cord blood transplantation for hematologic malignancy. 
  • Effect of neuronol on lifespan and development of spontaneous tumors in SAMP-1 mice with genetically accelerated aging. 
  • Effects of the methoxymorpholino derivative of doxorubicin and its bioactivated form versus doxorubicin on human leukemia and lymphoma cell lines and normal bone marrow. 
  • Efficacy of Pharmacokinetics-Directed Busulfan, Cyclophosphamide, and Etoposide Conditioning and Autologous Stem Cell Transplantation for Lymphoma: Comparison of a Multicenter Phase II Study and CIBMTR Outcomes. 
  • Elimination of clonogenic malignant human T cells using monoclonal antibodies in combination with 2'-deoxycoformycin. 
  • Elimination of malignant clonogenic T cells from human bone marrow using chemoimmunoseparation with 2'-deoxycoformycin, deoxyadenosine and an immunotoxin. 
  • Elimination of mycoplasma from human B-lymphoblastoid cell lines. 
  • Engraftment in 86 with patients lymphoid malignancy after autologous marrow transplantation. 
  • Enhanced chemotherapy delivery by intraarterial infusion and blood-brain barrier disruption in malignant brain tumors: the Sherbrooke experience. 
  • Epidemiology of primary malignant non-osseous spinal tumors in the United States. 
  • Etoposide, cyclophosphamide and fractionated total body irradiation as a preparative regimen for marrow transplantation in patients with advanced hematological malignancies: a phase I study. 
  • Evaluation of thiamine for the prevention of ifosfamide-induced encephalopathy. 
  • Expanding anti-CD38 immunotherapy for lymphoid malignancies. 
  • Expression profiling of a transformed thymocyte cell line undergoing maturation in vitro identifies multiple genes involved in positive selection. 
  • Fibrinogen kinetics in patients with neoplastic disease. 
  • Flow cytometry immunophenotyping of vitreous specimens does not contribute to diagnosis of lymphoma without supporting morphologic features. 
  • Focal Rosai-Dorfman disease coexisting with lymphoma in the same anatomic site: a localized histiocytic proliferation associated with MAPK/ERK pathway activation. 
  • Focal lesions in cirrhotic liver: what else beyond hepatocellular carcinoma? 
  • Frequent detection of bcl-2/JH translocations in human blood and organ samples by a quantitative polymerase chain reaction assay. 
  • Frequent loss of KAI1 expression in squamous and lymphoid neoplasms. An immunohistochemical study of archival tissues. 
  • GUCY2C Signaling Opposes the Acute Radiation-Induced GI Syndrome. 
  • Gastrointestinal involvement and multiple lymphomatous polyposis in mantle-zone lymphoma. 
  • Genetic convergence of rare lymphomas. 
  • Glycoconjugates and tumor metastasis. 
  • Graft-versus-host disease as adoptive immunotherapy in patients with advanced hematologic neoplasms. 
  • Granulocyte-macrophage colony-stimulating factor (GM-CSF) as an adjunct to autologous hemopoietic stem cell transplantation for lymphoma. 
  • Granulocyte-macrophage colony-stimulating factor as adjunct therapy in relapsed lymphoid malignancy: implications for economic analyses of phase III clinical trials. 
  • Hairy cell leukemia-associated familial lymphoproliferative disorder: immunologic abnormalities in unaffected family members. 
  • High-dose cyclophosphamide, carmustine, and etoposide followed by allogeneic bone marrow transplantation in patients with lymphoid malignancies who had received prior dose-limiting radiation therapy. 
  • High-dose cyclophosphamide, carmustine, and etoposide followed by autologous bone marrow transplantation in patients with lymphoid malignancies who have received dose-limiting radiation therapy. 
  • High-dose cytosine arabinoside, total body irradiation and marrow transplantation for advanced malignant lymphoma. 
  • High-dose methotrexate for primary CNS lymphoma in the elderly. 
  • Hodgkin disease/lymphoma. 
  • Homologous desensitization of beta-adrenergic receptor coupled adenylate cyclase. Resensitization by polyethylene glycol treatment. 
  • Host factors for risk and survival in lymphoma. 
  • Human T lymphocyte antigens as defined by monoclonal antibodies. 
  • Human lymphocyte differentiation antigens HB-10 and HB-11. I. Ontogeny of antigen expression. 
  • Hypoxia-inducible factor-1α plays roles in Epstein-Barr virus's natural life cycle and tumorigenesis by inducing lytic infection through direct binding to the immediate-early BZLF1 gene promoter. 
  • Id2 Collaborates with Id3 To Suppress Invariant NKT and Innate-like Tumors. 
  • Imaging of primary and secondary renal lymphoma. 
  • Imaging of primary multifocal osseous lymphoma. 
  • Immune (gamma) interferon production by a murine T cell lymphoma: requirements for macromolecular synthesis and lack of relationship with cell cycle. 
  • Importance of a c-Myb binding site for lymphomagenesis by the retrovirus SL3-3. 
  • In vivo antigenic modification of tumor cells. III. Metastatic thymic lymphoma specifically infected by thymotropic retrovirus. 
  • Inclusion of a sensitivity control to add a quality-control parameter and improve reproducibility in BCR, immunoglobulin, and T-cell receptor gene-rearrangement studies. 
  • Induction of type I IFN is required for overcoming tumor-specific T-cell tolerance after stem cell transplantation. 
  • Inflammatory Bowel Disease Patients' Willingness to Accept Medication Risk to Avoid Future Disease Relapse. 
  • Interferon alfa-2a in the treatment of cutaneous T cell lymphoma. 
  • Intramammary lymph nodes: cytologic findings and implications for fine-needle aspiration cytology diagnosis of breast nodules. 
  • Ion fluxes and differentiation in transformed cell lines. 
  • Langerhans cell histiocytosis associated with lymphoma: an incidental finding that is not associated with BRAF or MAP2K1 mutations. 
  • Leukemia/lymphoma in cerebrospinal fluid: distinguishing between cases that performed well and poorly in the College of American Pathologists Interlaboratory Comparison Program in Non-gynecologic Cytology. 
  • Leukemias and lymphomas of thymic differentiation. 
  • Linker for activation of T cells (LAT), a novel immunohistochemical marker for T cells, NK cells, mast cells, and megakaryocytes: evaluation in normal and pathological conditions. 
  • Long-term follow-up of patients who received recombinant human granulocyte-macrophage colony stimulating factor after autologous bone marrow transplantation for lymphoid malignancy. 
  • Longitudinal use of patient reported outcomes in pediatric leukemia and lymphoma reveals clinically relevant symptomatic adverse events. 
  • Loss of tumorigenicity following in vitro MuLV infection is associated with induction of peritoneal natural killer cell activity. 
  • Low plasma concentrations of retinol and alpha-tocopherol in hematopoietic stem cell transplant recipients: the effect of mucositis and the risk of infection. 
  • Lymph node infarction: role of underlying malignancy, tumour proliferation fraction and vascular compromise--a study of 35 cases and a comprehensive review of the literature. 
  • Lymphoma developing in a patient with rheumatoid arthritis taking low dose weekly methotrexate. 
  • Lymphoma models for B cell activation and tolerance. V. Anti-Ig mediated growth inhibition is reversed by phorbol myristate acetate but does not involve changes in cytosolic free calcium. 
  • Lymphoma of the female genital tract: current status. 
  • Lymphomas and high-grade astrocytomas: comparison of water diffusibility and histologic characteristics. 
  • Lymphomas or leukemia presenting as ovarian tumors. An analysis of 42 cases. 
  • Lymphomatoid Granulomatosis. Prospective clinical and therapeutic experience over 10 years. 
  • Lymphomatosis Cerebri: A Diagnostic Challenge. 
  • Lymphoproliferative lesions of the ocular adnexa. Analysis of 112 cases. 
  • MYD88 L265P elicits mutation-specific ubiquitination to drive NF-κB activation and lymphomagenesis. 
  • Macrophage migratory dysfunction in cancer. A mechanism for subversion of surveillance. 
  • Maculopathy as a complication of blood-brain barrier disruption in patients with central nervous system lymphoma. 
  • Malignancy Risk and Recurrence with Psoriasis and its Treatments: A Concise Update. 
  • Malignant melanoma with a myxoid stroma: a diagnostic pitfall on fine-needle aspiration biopsy. 
  • Management of extranodal lymphoma of the spine: a study of 30 patients. 
  • Manganese porphyrin, MnTE-2-PyP5+, Acts as a pro-oxidant to potentiate glucocorticoid-induced apoptosis in lymphoma cells. 
  • Marrow transplantation following escalating doses of fractionated total body irradiation and cyclophosphamide--a phase I trial. 
  • Mechanisms and treatments of neuropathic itch in a mouse model of lymphoma. 
  • Mediastinal large cell lymphoma. An uncommon subset of adult lymphoma curable with combined modality therapy. 
  • Metabolic Reprogramming and Potential Therapeutic Targets in Lymphoma. 
  • Methotrexate and cytarabine inhibit progression of human lymphoma in NOD/SCID mice carrying a mutant dihydrofolate reductase and cytidine deaminase fusion gene. 
  • Monocarboxylate transporter antagonism reveals metabolic vulnerabilities of viral-driven lymphomas. 
  • Monoclonal antibodies reactive with human T cell lymphotropic virusI (HTLVI) p19 internal core protein: cross-reactivity with normal tissues and differential reactivity with HTLV types I and II. 
  • Monoclonal immunoglobulin-secreting lymphoma in a patient with severe combined immunodeficiency disease. 
  • Multiple myeloma and family history of cancer. A case-control study. 
  • Multislice helical CT to facilitate combined CT of the neck, chest, abdomen, and pelvis in children. 
  • Musculoskeletal syndromes associated with malignancy. 
  • Mutation in the mismatch repair gene Msh6 causes cancer susceptibility. 
  • Mutational fingerprints of aging. 
  • NF-κB signaling pathway and its potential as a target for therapy in lymphoid neoplasms. 
  • Neurological disorders with abnormalities of immunoglobulin metabolism. 
  • New presentation of alpha heavy chain disease: North American polypoid gastrointestinal lymphoma. Clinical and cellular studies. 
  • O6-methylguanine-DNA methyltransferase (MGMT) immunohistochemistry as a predictor of resistance to temozolomide in primary CNS lymphoma. 
  • Ocular manifestations of hematologic disorders. 
  • Okadaic acid induces both augmentation and inhibition of beta 2-adrenergic stimulation of cAMP accumulation in S49 lymphoma cells. 
  • Oligonucleotide enhanced cytotoxicity of Idarubicin for lymphoma cells. 
  • On the role of human herpesvirus 6 in viral latency in nervous tissue and in cerebral lymphoma. 
  • Oncogenic Signaling Pathways and Pathway-Based Therapeutic Biomarkers in Lymphoid Malignancies. 
  • Oncogenic and immunogenic potential of cloned HIX virus in mice and cats. 
  • One and a half decades of the Lugano International Conference on Malignant Lymphoma: variations on a theme or true progress? 
  • Organ transplantation in HIV-infected patients. 
  • Outcomes among 562 recipients of placental-blood transplants from unrelated donors. 
  • Outcomes of tracheobronchial stents in patients with malignant airway disease. 
  • PAK1 mediates resistance to PI3K inhibition in lymphomas. 
  • PMS2 endonuclease activity has distinct biological functions and is essential for genome maintenance. 
  • Pancreatic FNA in 1000 cases: a comparison of imaging modalities. 
  • Patient perspectives on physical function after allogeneic hematopoietic stem cell transplantation: a qualitative study. 
  • Pediatric lymphoma patients in Malawi present with poor health-related quality of life at diagnosis and improve throughout treatment and follow-up across all Pediatric PROMIS-25 domains. 
  • Phase I evaluation of doxorubicin and whole-body hyperthermia in dogs with lymphoma. 
  • Phase I evaluation of mitoxantrone alone and combined with whole body hyperthermia in dogs with lymphoma. 
  • Phase I evaluation of prolonged-infusion gemcitabine with irinotecan for relapsed or refractory leukemia or lymphoma. 
  • Phase I/II dose escalation study of recombinant human interleukin-11 following ifosfamide, carboplatin and etoposide in children, adolescents and young adults with solid tumours or lymphoma: a clinical, haematological and biological study. 
  • Phase II trial of recombinant human granulocyte-macrophage colony-stimulating factor in patients undergoing allogeneic bone marrow transplantation from unrelated donors. 
  • Phenotypic and functional characterization of human malignant T cells. 
  • Phenotypic characterization of skin-infiltrating T cells in cutaneous T-cell lymphoma: comparison with benign cutaneous T-cell infiltrates. 
  • Pitfalls of Combining Novel Agents in Lymphoma. 
  • Poland's syndrome and lymphoma. 
  • Poland's syndrome associated with childhood non-Hodgkin's lymphoma. 
  • Potential for a novel manganese porphyrin compound as adjuvant canine lymphoma therapy. 
  • Prevalence of a Histologic Change of Ocular Adnexal Lymphoma in Patients With a History of Lymphoma. 
  • Primary CNS lymphoma in HIV positive and negative patients: comparison of clinical characteristics, outcome and prognostic factors. 
  • Primary Pulmonary Lymphomas. 
  • Primary cardiac lymphoma. 
  • Primary central nervous system lymphomas: a 30-year experience at a single institution. 
  • Primary cutaneous lymphoma of the head and neck. 
  • Primary gastrointestinal lymphoma. 
  • Primary pancreatic lymphoma evaluated by fine-needle aspiration: findings in 14 cases. 
  • Prognostic value of cell-cycle markers in ocular adnexal lymphoma: an assessment of 230 cases. 
  • Quantitative analysis of Pc 4 localization in mouse lymphoma (LY-R) cells via double-label confocal fluorescence microscopy. 
  • Radiation-induced reductions in regional lung perfusion: 0.1-12 year data from a prospective clinical study. 
  • Radioimmunotherapy with alpha-particle emitting radioimmunoconjugates. 
  • Radiologic imaging of AIDS. 
  • Re: Researchers make slow headway in managing dry mouth. 
  • Recovery after allogeneic marrow transplantation: prospective study of predictors of long-term physical and psychosocial functioning. 
  • Regional lung density changes after radiation therapy for tumors in and around thorax. 
  • Regression models for prognostic prediction: advantages, problems, and suggested solutions. 
  • Relatedness by nucleic acid hybridization of new isolates of human T-cell leukemia-lymphoma virus (HTLV) and demonstration of provirus in uncultured leukemic blood cells. 
  • Relating radiation-induced regional lung injury to changes in pulmonary function tests. 
  • Resistance of neoplasms to immunological destruction: role of a macrophage chemotaxis inhibitor. 
  • Resolution of nephrocalcinosis associated with tumor lysis syndrome. 
  • Resolution of radiation necrosis with bevacizumab following radiation therapy for primary CNS lymphoma. 
  • Restoration of p53 function leads to tumour regression in vivo. 
  • Rheumatologic manifestations of cancer. 
  • Richter's syndrome mimicking chronic colitis. A patient with diffuse histiocytic lymphoma complicating chronic lymphocytic leukemia. 
  • Role of etoposide (VP-16) in preparatory regimens for patients with leukemia or lymphoma undergoing allogeneic bone marrow transplantation. 
  • SMRT Sequencing for Parallel Analysis of Multiple Targets and Accurate SNP Phasing. 
  • SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype. 
  • Second malignancies in cutaneous T cell lymphoma. 
  • Selection of patients with Hodgkin's disease and non-Hodgkin's lymphoma for bone marrow transplantation. 
  • Selective probing and imaging of cells with single walled carbon nanotubes as near-infrared fluorescent molecules. 
  • Sentinel lymph node biopsy following a rotational flap. 
  • Septic arthritis due to Mycoplasma hominis. 
  • Signaling pathway and dysregulation of PD1 and its ligands in lymphoid malignancies. 
  • Simulated microgravity-mediated reversion of murine lymphoma immune evasion. 
  • Small-bowel malabsorption and gastrointestinal malignancy. 
  • Somatostatin induces translocation of the beta-adrenergic receptor kinase and desensitizes somatostatin receptors in S49 lymphoma cells. 
  • Some characteristics of mouse immune (y) interferon produced by a T-lymphoma cell line. 
  • Stereotactic radiosurgery in the treatment of primary central nervous system lymphoma. 
  • Surgical management of pancreatic lymphoma. 
  • Survivin DNA vaccine generated specific antitumor effects in pancreatic carcinoma and lymphoma mouse models. 
  • Synergistic control of T cell development and tumor suppression by diacylglycerol kinase alpha and zeta. 
  • Targeting the programmed death-1 pathway in lymphoid neoplasms. 
  • Technical Aspects of Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration: CHEST Guideline and Expert Panel Report. 
  • The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms. 
  • The PTEN tumor suppressor gene and its role in lymphoma pathogenesis. 
  • The TP53 tumor suppressor and autophagy in malignant lymphoma. 
  • The beta-adrenergic receptor kinase: role in homologous desensitization in S49 lymphoma cells. 
  • The biology of human lymphoid malignancies revealed by gene expression profiling. 
  • The elderly left behind-changes in survival trends of primary central nervous system lymphoma over the past 4 decades. 
  • The increasing incidence of malignant gliomas and primary central nervous system lymphoma in the elderly. 
  • The influence of oxidative stress on symptom occurrence, severity, and distress during childhood leukemia treatment. 
  • The role of endoscopy in the evaluation and treatment of patients with biliary neoplasia. 
  • The tumor dormant state. Comparison of L5178Y cells used to establish dormancy with those that emerge after its termination. 
  • The tumor dormant state. Quantitation of L5178Y cells and host immune responses during the establishment and course of dormancy in syngeneic DBA/2 mice. 
  • The use of a panel of monoclonal antibodies in the evaluation of cytologic specimens from the central nervous system. 
  • The use of convex probe endobronchial ultrasound-guided transbronchial needle aspiration in a pediatric population: a multicenter study. 
  • The use of non-human primates for production of antisera to human tumor-associated antigens. 
  • Therapeutic effects of diethylcarbamazine and 3'-azido-3'-deoxythymidine on feline leukemia virus lymphoma formation. 
  • Thromboembolism in hospitalized neutropenic cancer patients. 
  • Towards a genomic-based diagnosis. 
  • Transformation of hairy cell leukemia to EBV genome-containing aggressive B cell lymphoma. 
  • Translation, psychometric validation, and baseline results of the Patient-Reported Outcomes Measurement Information System (PROMIS) pediatric measures to assess health-related quality of life of patients with pediatric lymphoma in Malawi. 
  • Transplantation of Unirradiated Bone Marrow Cells after Total-Body Irradiation Prevents the Development of Thymic Lymphoma in Mice through Niche Competition. 
  • Treatment of cutaneous T cell lymphoma with 2'-deoxycoformycin (pentostatin). 
  • Treatment of malignant lymphoma in 100 patients with chemotherapy, total body irradiation, and marrow transplantation. 
  • Treatment of non-Hodgkin's lymphoma with chemoradiotherapy and allogenic marrow transplantation. 
  • Tumour cell kinetics as predictors of response in canine lymphoma treated with chemotherapy alone or combined with whole body hyperthermia. 
  • Tumour-dormant states established with L5178Y lymphoma cells in immunised syngeneic murine hosts. 
  • Umbralisib, a novel PI3Kδ and casein kinase-1ε inhibitor, in relapsed or refractory chronic lymphocytic leukaemia and lymphoma: an open-label, phase 1, dose-escalation, first-in-human study. 
  • Use of cytosar in pediatric non-Hodgkin lymphoma. 
  • Weekly mitoxantrone therapy for refractory multiple myeloma: a Southeastern Cancer Study Group Trial. 
  • Weight loss, fatigue, and mediastinal and hilar adenopathy in a 67-year-old man. 
  • Whole-Exome Sequencing of Radiation-Induced Thymic Lymphoma in Mouse Models Identifies Notch1 Activation as a Driver of p53 Wild-Type Lymphoma. 
  • miR-19 is a key oncogenic component of mir-17-92. 
• 

  Keywords of People

  • Jowell, Paul Simon, Professor of Medicine, Medicine, Gastroenterology
  • Lagoo, Anand Shreeram, Professor of Pathology, Pathology
  • LeBlanc, Thomas William, Associate Professor of Medicine, Duke Cancer Institute
  • McLendon, Roger Edwin, Professor of Pathology, Pathology
  • Rodgers, Thomas, Assistant Professor of Medicine, Duke Cancer Institute
  • Sitlinger, Andrea, Assistant Professor of Medicine, Duke Cancer Institute
  • Stefanovic, Alexandra, Associate Professor of Medicine, Medicine, Hematologic Malignancies and Cellular Therapy
  • Weinhold, Kent James, Joseph W. and Dorothy W. Beard Distinguished Professor of Experimental Surgery, Integrative Immunobiology
  • Young, Ken H, Professor of Pathology, Pathology